The effect of non-invasive sequential ventilation treatment based on the use of an invasive ventilator on the arterial blood gas and inflammatory stress reaction in patients with severe pneumonia with respiratory failure

To investigate the impact of non-invasive sequential ventilation treatment based on the use of an invasive ventilator on the arterial blood gas and inflammatory stress reaction in patients with severe pneumonia with respiratory failure. Ninety patients with severe pneumonia and respiratory failure were equally separated into two groups via a random number table: a conventional treatment group (subjected to invasive mechanical ventilation) and a study group (subjected to invasive mechanical ventilation and non-invasive sequential ventilation treatment). We compared the two groups with respect to several key parameters before and after treatment, including mechanical ventilation time, invasive ventilation time, intensive care unit (ICU) stay, hospital stay, blood gas analysis indicators and the levels of inflammatory factors in the serum. We also compared the two groups with regards to complications. Mechanical ventilation time, invasive ventilation time, ICU stay and hospital stay in the study group were significantly shorter than that in the conventional treatment group (p < 0.05). Arterial Oxygen Saturation (SaO2), Partial Pressure of Oxygen (PaO2) and pH in the study group after intervention were significantly higher than those in the conventional treatment group after intervention (p < 0.05). Following intervention, white blood cell (WBC), serum c-reactive protein (CRP) and serum interleukin-6 (IL-6) were significantly lower than those in the conventional treatment group (p < 0.05). The total incidence of complications in the study group was markedly lower than in the conventional treatment group. Non-invasive sequential ventilation therapy based on an invasive ventilator had a significant treatment impact on patients with severe pneumonia and respiratory failure. This treatment effectively reduced the average treatment time, improved blood gas analysis indicators and reduced inflammatory stress, thus reducing the incidence of complications.

Severe pneumonia; Respiratory failure; Invasive mechanical ventilation; Non-invasive sequential ventilation; Blood gas analysis; Inflammatory factor

[1] Cilloniz C, Pericàs JM, Rojas J. Ceftaroline in severe community-acquired pneumonia. The Journal of Spanish Chemotherapy. 2022; 35: 28–30.

[2] Bartoš H, Džupová O. Severe community-acquired pneumonia in intensive care. Epidemiologie, Mikrobiologie, Imunologie. 2020; 69: 159–163.

[3] Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020; 142: 1176–1189.

[4] Wilcox SR, Condella A. Emergency department management of severe hypoxemic respiratory failure in adults with COVID-19. The Journal of Emergency Medicine. 2021; 60: 729–742.

[5] Shang P, Zhu M, Baker M, Feng J, Zhou C, Zhang H. Mechanical ventilation in Guillain-Barré syndrome. Expert Review of Clinical Immunology. 2020; 16: 1053–1064.

[6] Aquino Esperanza J, Sarlabous L, de Haro C, Magrans R, Lopez-Aguilar J, Blanch L. Monitoring asynchrony during invasive mechanical ventilation. Respiratory Care. 2020; 65: 847–869.

[7] Mitting RB, Peshimam N, Lillie J, Donnelly P, Ghazaly M, Nadel S, et al. Invasive mechanical ventilation for acute viral bronchiolitis: retrospective multicenter cohort study. Pediatric Critical Care Medicine. 2021; 22: 231–240.

[8] Zuercher P, Schenk NV, Moret C, Berger D, Abegglen R, Schefold JC. Risk factors for dysphagia in ICU patients after invasive mechanical ventilation. Chest. 2020; 158: 1983–1991.

[9] Kang N, Zhang N, Luo B, Wu E, Shi J, Li L, et al. Sequential non-invasive following short-term invasive mechanical ventilation in the treatment of tuberculosis with respiratory failure: a randomized controlled study. BMC Pulmonary Medicine. 2021; 21: 203.

[10] Cillóniz C, Torres A, Niederman MS. Management of pneumonia in critically ill patients. The BMJ. 2021; 375: e065871.

[11] Saguil A, Fargo MV. Acute respiratory distress syndrome: diagnosis and management. American Family Physician. 2020; 101: 730–738.

[12] Grieco DL, Menga LS, Cesarano M, Rosà T, Spadaro S, Bitondo MM, et al. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA. 2021; 325: 1731–1743.

[13] Marti C, Garin N, Grosgurin O, Poncet A, Combescure C, Carballo S, et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Critical Care. 2012; 16: R141.

[14] Barcellos RA, Chatkin JM. Impact of a multidisciplinary checklist on the duration of invasive mechanical ventilation and length of ICU stay. Brazilian Journal of Pulmonary Disease. 2020; 46: e20180261.

[15] Zarrabian B, Wunsch H, Stelfox HT, Iwashyna TJ, Gershengorn HB. Liberation from invasive mechanical ventilation with continued receipt of vasopressor infusions. American Journal of Respiratory and Critical Care Medicine. 2022; 205: 1053–1063.

[16] Urner M, Jüni P, Hansen B, Wettstein MS, Ferguson ND, Fan E. Time-varying intensity of mechanical ventilation and mortality in patients with acute respiratory failure: a registry-based, prospective cohort study. The Lancet Respiratory Medicine. 2020; 8: 905–913.

[17] Yang SQ, Liu Z, Meng SQ, Yang WB, Zhang GZ, Shi QB, et al. Application value of non-invasive ventilation combined with high flow nasal cannula oxygen therapy in sequential treatment of patients with chronic obstructive pulmonary disease after mechanical ventilation. Zhonghua Yi Xue Za Zhi. 2020; 100: 2116–2120. (In Chinese)

[18] De Pascale G, Cutuli SL, Carelli S, Xhemalaj R, Rosà T, Bello G, et al. Remdesivir plus dexamethasone in COVID-19: a cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation. PLOS ONE. 2022; 17: e0267038.

[19] Suttapanit K, Boriboon J, Sanguanwit P. Risk factors for non-invasive ventilation failure in influenza infection with acute respiratory failure in emergency department. The American Journal of Emergency Medicine. 2021; 45: 368–373.

[20] Bathe J, Malik S, Pinnschmidt HO, Zitzmann A, Behem CR, Trepte CC, et al. Effectiveness of preoxygenation by conventional face mask versus non-invasive ventilation in morbidly obese patients: measurable by the oxygen-reserve index? Journal of Clinical Monitoring and Computing. 2022; 36: 1767–1774.

[21] Li XQ, Zhao WL, Li DY, Lei L, Luo LL, Qiao LN. Clinical study on early extubation and sequential non-invasive respiratory support for children with acute respiratory failure receiving invasive mechanical ventilation. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022; 53: 321–326. (In Chinese)

[22] Wang S, Liang H, Lu G, Jiang Z, Zhang B, Deng Q, et al. Effect of sequential high-flow nasal cannula oxygen therapy and non-invasive positive-pressure ventilation in patients with difficult weaning from mechanical ventilation after extubation on respiratory mechanics. Annals of Translational Medicine. 2021; 9: 1251.

[23] Wang C, Shang M, Huang K, Tong Z, Kong W, Jiang C, et al. Sequential non-invasive mechanical ventilation following short-term invasive mechanical ventilation in COPD induced hypercapnic respiratory failure. Chinese Medical Journal. 2003; 116: 39–43.

[24] Huang J, Gu T, Hu Z, Zhou D, Ying J. Invasive-noninvasive sequential ventilation for the treatment of acute exacerbation of chronic obstructive pulmonary disease. Combinatorial Chemistry & High Throughput Screening. 2019; 22: 160–168.

[25] Korang SK, Feinberg J, Wetterslev J, Jakobsen JC. Non-invasive positive pressure ventilation for acute asthma in children. Cochrane Database of Systematic Reviews. 2016; 9: CD012067.

[26] Fang G, Wan Q, Tian Y, Jia W, Luo X, Yang T, et al. Comparative study on pros and cons of sequential high-flow nasal cannula and non-invasive positive pressure ventilation immediately following early extubated patients with severe respiratory failure due to acute exacerbations of chronic obstructive pulmonary disease. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021; 33: 1215–1220. (In Chinese)

[27] Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biology. 2020; 10: 200160.

[28] Stasiow B, Sosna M, Młynarska A, Młynarski R. Severity of inflammatory lung lesions in COVID‑19 based on computed tomography examination as a prognostic factor for respiratory failure and death. Polish Archives of Internal Medicine. 2021; 131: 882–884.

[29] Xuan L, Ma J, Tao J, Zhu L, Lin S, Chen S, et al. Comparative study of high flow nasal catheter device and noninvasive positive pressure ventilation for sequential treatment in sepsis patients after weaning from mechanical ventilation in intensive care unit. Annals of Palliative Medicine. 2021; 10: 6270–6278.

[30] Yang W, Zhang L. Observation of the curative effect of conservative oxygen therapy in mechanical ventilation of patients with severe pneumonia. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021; 33: 1069–1073. (In Chinese)